XML 60 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Summary of Financial Liabilities Measured at Fair Value on Recurring Basis

As of December 31, the following financial liabilities are measured at fair value on a recurring basis using significant unobservable inputs (Level 3).

 

 

 

2022

 

 

2021

 

Interest rate swap(1)

 

$

6,046

 

 

$

 

Total assets

 

$

6,046

 

 

$

 

 

 

 

 

 

 

 

Business acquisitions contingent consideration,
   current

 

$

3,801

 

 

$

31,450

 

Business acquisitions contingent consideration,
   long-term

 

 

4,454

 

 

 

4,350

 

Conversion option

 

 

25,731

 

 

 

23,081

 

Total liabilities

 

$

33,986

 

 

$

58,881

 

_____________________________

(1) Included in other assets in the Consolidated Statement of Financial Position.

Summary of Financial Instruments Measured at Fair Value on Recurring Basis

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis:

 

 

 

Level 3

 

 

 

Interest
Rate
Swap

 

 

Total
Assets

 

 

Business
Acquisitions
Contingent
Consideration,
Current

 

 

Business
Acquisitions
Contingent
Consideration,
Long-term

 

 

Conversion Option

 

 

Contingent
Put Option

 

 

Warrant
Options

 

 

Total
Liabilities

 

Balance—at January 1, 2020

 

$

 

 

$

 

 

$

8,614

 

 

$

379

 

 

$

 

 

$

7,100

 

 

$

16,878

 

 

$

32,971

 

Acquisitions

 

 

 

 

 

 

 

 

34,661

 

 

 

10,543

 

 

 

 

 

 

 

 

 

 

 

 

45,204

 

Series A-2 compound embedded option

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9,361

)

 

 

 

 

 

 

 

 

(9,361

)

Issuance of warrant option

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30,097

 

 

 

30,097

 

Changes in fair value included in
earnings

 

 

 

 

 

 

 

 

19,119

 

 

 

(6,177

)

 

 

30,247

 

 

 

(19,240

)

 

 

9,312

 

 

 

33,261

 

Payment of contingent consideration
   payable

 

 

 

 

 

 

 

 

(12,464

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(12,464

)

Reclass of long term to short term
   contingent liabilities

 

 

 

 

 

 

 

 

180

 

 

 

(180

)

 

 

 

 

 

 

 

 

 

 

 

 

Write off of the contingent put
   option

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,140

 

 

 

 

 

 

12,140

 

Exercise of warrant options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(56,287

)

 

 

(56,287

)

Foreign currency translation of
   contingent consideration payment

 

 

 

 

 

 

 

 

(208

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(208

)

Balance—at December 31, 2020

 

$

 

 

$

 

 

$

49,902

 

 

$

4,565

 

 

$

20,886

 

 

$

 

 

$

 

 

$

75,353

 

Acquisitions

 

 

 

 

 

 

 

 

2,801

 

 

 

4,603

 

 

 

 

 

 

 

 

 

 

 

 

7,404

 

Series A-2 compound embedded option

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,195

 

 

 

 

 

 

 

 

 

2,195

 

Changes in fair value included in
earnings

 

 

 

 

 

 

 

 

14,111

 

 

 

10,261

 

 

 

 

 

 

 

 

 

 

 

 

24,372

 

Payment of contingent consideration
   payable

 

 

 

 

 

 

 

 

(50,443

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(50,443

)

Reclass of long term to short term
   contingent liabilities

 

 

 

 

 

 

 

 

15,079

 

 

 

(15,079

)

 

 

 

 

 

 

 

 

 

 

 

 

Balance—at December 31, 2021

 

$

 

 

$

 

 

$

31,450

 

 

$

4,350

 

 

$

23,081

 

 

$

 

 

$

 

 

$

58,881

 

Acquisitions

 

 

 

 

 

 

 

 

 

 

 

2,666

 

 

 

 

 

 

 

 

 

 

 

 

2,666

 

Changes in fair value included in
earnings

 

 

6,046

 

 

 

6,046

 

 

 

500

 

 

 

(196

)

 

 

2,650

 

 

 

 

 

 

 

 

 

2,954

 

Payment of contingent consideration
   payable

 

 

 

 

 

 

 

 

(30,515

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(30,515

)

Reclass of long term to short term
   contingent liabilities

 

 

 

 

 

 

 

 

2,366

 

 

 

(2,366

)

 

 

 

 

 

 

 

 

 

 

 

 

Balance—at December 31, 2022

 

$

6,046

 

 

$

6,046

 

 

$

3,801

 

 

$

4,454

 

 

$

25,731

 

 

$

 

 

$

 

 

$

33,986

 

 

Summary of Fair Value of Warrant Options Associated with Issuance of Redeemable Preferred Stock The fair value of the warrant options associated with the issuance of the Redeemable Series A-1 Preferred Stock and the Convertible and Redeemable Series A-2 Preferred Stock was calculated based on the Black-Sholes pricing model using the following assumptions:

 

 

 

July 30, 2020

 

Common stock value (per share)

 

$

22.22

 

Expected volatility

 

 

44.35

%

Risk-free interest rate

 

 

0.55

%

Expected life (years)

 

 

10